Angusta 25 Mikrogramm Tabletten
Recall
|
Medicines
|
27/06/2022
The marketing authorisation holder informed its customers on June 24, 2022, that due to contamination the mentioned medicinal product is recalled as a precautionary measure. The risk of the contamination has been determined to be low.
| Name of the medicinal product | Angusta 25 Mikrogramm Tabletten |
|---|---|
| Marketing authorisation number(s) | 140316 |
| CIP code | 4984654 |
| Marketing authorisation holder | Norgine B.V. |
| Batch number(s) | Batch, Expiry Date B27754, 30.09.2023 B28186, 31.08.2024 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
Further inquiry note
Page last modified:
27/06/2022